Immunodiagnostics Market Growth Report | Size & Share 2030
[Research Report] The immunodiagnostics market size is expected to grow to US$ 34,487.80 million by 2030 from US$ 19,218.89 million in 2022; the immunodiagnostics market is estimated to register a CAGR of 7.6% from 2022 to 2030.
Analyst Perspective:
The immunodiagnostics market is expected to flourish due to the significant rise in the developments in the diagnostic sector. The immunodiagnostics market growth was boosted during the COVID-19 pandemic. Various companies received emergency authorizations for their products that helped them commercialize into the market. In addition, the growth of the market was majorly attributed to the increased investments in research and development of faster diagnostics techniques. Companies made various strategic decisions to expand their product portfolio and geographic presence. In addition, the improved life expectancy has led to a significant rise in geriatric population, contributing to increased demand for immunodiagnostics. Moreover, the increasing awareness among people and changing health standards have increased the demand for early diagnosis, which has propelled the demand for various devices for diagnosis. Also, the awareness about the developments in immunodiagnostics and its benefits has increased the usage of immunodiagnostic techniques.
Market Overview:
Immunodiagnostics is referred to as a diagnostic methodology that primarily uses antigen-antibody reaction as its primary means of detection. Antibodies specific to a desired antigen can be conjugated with a radiolabel, fluorescent label, or color-forming enzyme and are used as a probe to detect it. The speed, accuracy, and simplicity of such tests have led to the development of rapid techniques for the diagnosis of diseases, microbes, and even illegal drugs in vivo. The key factors that are driving the rising prevalence of infectious diseases and the growing use of point-of-care propel immunodiagnostics market growth. However, inadequate reimbursements hinder market growth. Geographically, North America is the largest market and followed by Europe. In North America, the US holds the maximum market share of the immunodiagnostics market. Asia Pacific is the fastest-growing region in the global immunodiagnostics market. In Asia Pacific, China is the largest market for immunodiagnostics and is expected to retain its dominance during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Immunodiagnostics Market: Strategic Insights
Market Size Value in US$ 19,218.89 million in 2022 Market Size Value by US$ 34,487.80 million by 2030 Growth rate CAGR of 7.6% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Immunodiagnostics Market: Strategic Insights
| Market Size Value in | US$ 19,218.89 million in 2022 |
| Market Size Value by | US$ 34,487.80 million by 2030 |
| Growth rate | CAGR of 7.6% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver:
Increasing Prevalence of Infectious Diseases
The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are surging number of prescriptions for immunodiagnostic tests, e.g., complement fixation, precipitation tests, agglutination tests, line blot assays, Western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests.
Human immunodeficiency virus (HIV) continues to be a major public health issue worldwide. In 2021, there were ~38.4 million people worldwide with HIV, as per the Joint United Nations Programme on HIV/AIDS (UNAIDS). Besides, hepatitis is another major factor driving the immunodiagnostics market. According to the World Health Organization (WHO), nearly 58 million people worldwide suffer from chronic hepatitis C infection, with 1.5 million new conditions occurring yearly. Furthermore, about 3.2 million adolescents and children have hepatitis C infection. Approved by all member states, the global hepatitis WHO strategy aims to reduce new hepatitis infections by 90% and mortalities by 65% during 2016–2030. Such global initiatives are fueling the demand for immunodiagnostic products.
Further, tuberculosis (TB), COVID-19, and other hospital-acquired infections (HAIs) require immunodiagnostic tests.
- TB has been the 13th leading cause of death and the second-leading infectious killer after COVID-19. In 2020, 1.5 million people died from TB and affected an estimated 10 million people, comprising 5.6 million males, 3.3 million females, and 1.1 million children globally.
- In 2021, a total of 7,860 TB cases were reported to CDC's National Tuberculosis Surveillance System (NTSS) by the 50 states of America and the District of Columbia (DC).
- According to Worldometer, millions of deaths were reported worldwide due to the COVID-19 pandemic. It strained healthcare systems and increased the need for immunodiagnostic tests.
Diagnostics play a vital role in determining suitable medical treatments. Immunodiagnostics help diagnose diseases that severely impact the immune system. Thus, the rising prevalence of infectious diseases leads to the surging demand for immunodiagnostic products.
Segment Analysis:
The global immunodiagnostics market is segmented into product, clinical indication, and end user. Based on product, the market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment held the largest market share of the market by product. Infectious diseases are caused by harmful pathogens such as bacteria, viruses, parasites, and fungi entering the body. They are commonly spread through contaminated food or water and bug bites. Contagious diseases cover a significant section of the immunodiagnostics market. Immunodiagnostics tests are performed to complement the results of molecular assays in infectious disease studies. Several immunodiagnostic tests are employed to diagnose infectious diseases, detect endocrine and neoplastic disorders, and measure blood drug concentrations. Enzyme-based immunoassays use antibodies to detect antigens and quantify antibodies. A Western blot test involves detecting antibodies in patients’ samples such as serum or different body fluids based on reactions between antibodies and target antigens (viral components) immobilized into a membrane by blotting.
The chemiluminescence immunoassays (CLIA) segment is anticipated to register the highest CAGR during the forecast period. The CLIA segment is further segmented into vitamin D assay, HIV detection, HIV AG/AB combo assay, and others.
Based on clinical indication, the market is segmented into infectious diseases, hepatitis+hiv, endocrinology, gastrointestinal, metabolic, and others. Infectious diseases acquired the highest market value in 2022and is expected to register the highest CAGR during the forecast period. The infectious disease segment is further segmented into COVID-19, tuberculosis, Lyme, infection management, Zika, treponema, TORCH, measles and mumps, VZV, and EBV. Similarly, the endocrinology segment is further classified into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.
Based on end user, the immunodiagnostics market is classified into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospitals segment held the largest share of the market in 2022. The clinics segment is anticipated to register the highest CAGR during the forecast period.
Regional Analysis:
North America held the largest market share of the global immunodiagnostics market, which was valued at US$ 9,772.80 million in 2022, with a CAGR of 7.5%. North America is the largest market for immunodiagnostics, with the US, Canada, and Mexico being the major contributors to this regional market. The growing government support for adopting advanced diagnostics, increasing R&D efforts, and initiatives such as strategic collaborations by market players contribute to significant immunodiagnostics market growth. In addition, technological advancements by the players operating in the diagnosis industry will likely be a major growth stimulator for the immunodiagnostics market in North America over the coming years. At the same time, Asia Pacific is the fastest-growing region in the global immunodiagnostics market. The US is the largest market, and the immunodiagnostics growth is driven by the increasing prevalence of cancer that demands diagnosis and growing developments in the field of immunodiagnostics.
The Asia Pacific immunodiagnostics market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. The increasing frequency of chronic illnesses in APAC resulted in high demand for diagnostic tests that provide essential details of medical care with detection, diagnostics, and therapy related to the diseases. In addition, the investment of domestic players to develop immunodiagnostics products and technologies is likely to propel the immunodiagnostics market growth during the forecast period.
Immunodiagnostics Market Report Scope
Key Player Analysis:
The immunodiagnostics market majorly consists of players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Danaher Corp, Thermo Fisher Scientific Inc, PerkinElmer Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, bioMerieux SA, Svar Life Science AB, and Siemens Healthineers AG.
Abbott Laboratories and F. Hoffmann-La Roche Ltd are the top two players in the immunodiagnostics market. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. On the flip side, inorganic strategies, such as product launches, partnerships, and collaborations, were widely seen in the immunodiagnostics market.
Recent Developments:
Inorganic and organic strategies are highly adopted by companies in the immunodiagnostics market. A few recent key market developments are listed below:
- In April 2023, Thermo Fisher Scientific announced a partnership with ALPCO-GeneProof, a global leader in diagnostics. The partnership has helped in bringing TaqPath Menu | GeneProof PCR kits into the market.
- In July 2022, Abbott Diagnostics announced its participation in American Association for Clinical Chemistry (AACC) 2022. In the exhibition, the company demonstrated its diagnostics systems and analyzers.
- In May 2023, Thermo Fisher Scientific announced that the US FDA had cleared its immunoassays, B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR novel biomarkers. These immunoassays assess risks and clinical management of preeclampsia, a severe pregnancy complication.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Clinical Indication, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The enzyme-linked immunosorbent assays (ELISA) segment held the largest share of the market in 2022. Whereas the chemiluminescence immunoassays (CLIA) segment is estimated to register the highest CAGR in the market during the forecast period.
The immunodiagnostics market is expected to be valued at US$ 34,487.80 million in 2030.
The immunodiagnostics market is estimated to be valued at US$ 19,218.89 million in 2022.
The CAGR value of the immunodiagnostics market during the forecasted period of 2022-2028 is 7.6%.
The Asia Pacific is expected to be the fastest-growing region in the immunodiagnostics market over the forecast period due to the infectious diseases and the growing use of point-of-care immunodiagnostics, and developments by market players offering immunodiagnostics.
The immunodiagnostics market majorly consists of the players, such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Danaher Corp, Thermo Fisher Scientific Inc, PerkinElmer Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, bioMerieux SA, Svar Life Science AB, and Siemens Healthineers AG.
The factors that are driving the growth of the immunodiagnostics market are the rising prevalence of infectious diseases and the growing use of point-of-care immunodiagnostics.
Immunodiagnostics is referred as a diagnostic methodology that primarily uses antigen-antibody reaction as its primary means of detection. Antibodies specific for a desired antigen can be conjugated with a radiolabel, fluorescent label, or color-forming enzyme and are used as a probe to detect it. The speed, accuracy and simplicity of such tests has led to the development of rapid techniques for the diagnosis of disease, microbes and even illegal drugs in vivo.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Immunodiagnostics Market – by Product
1.3.2 Global Immunodiagnostics Market – by Clinical Indication
1.3.3 Global Immunodiagnostics Market – by End User
1.3.4 Global Immunodiagnostics Market – by Geography
2. Immunodiagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Immunodiagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.2.6 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. Immunodiagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Growing Use of Point-of-Care Immunodiagnostics
5.2 Market Restraints
5.2.1 Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
5.4 Future Trends
5.4.1 Technological Advancements in Immunodiagnostics
5.5 Impact Analysis
6. Immunodiagnostics Market – Global Analysis
6.1 Global Immunodiagnostics Market Revenue Forecast and Analysis
6.2 Global Immunodiagnostics Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Immunodiagnostics Market Analysis – by Product
7.1 Overview
7.2 Immunodiagnostics Market, By Product, 2022 & 2030 (%)
7.3 Enzyme-linked Immunosorbent Assays (ELISA)
7.3.1 Overview
7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4 Chemiluminescence Immunoassays (CLIA)
7.4.1 Overview
7.4.2 Chemiluminescence Immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.3 Vitamin D Assay
7.4.3.1 Overview
7.4.3.2 Vitamin D Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.4 HIV Detection
7.4.4.1 Overview
7.4.4.2 HIV Detection: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.5 HIV Ag/Ab Combo assay
7.4.5.1 Overview
7.4.5.2 HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.4.6 Other Tests
7.4.6.1 Overview
7.4.6.2 Other Tests: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.5 Radioimmunoassays (RIA)
7.5.1 Overview
7.5.2 Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8. Immunodiagnostics Market Analysis – Clinical Indication
8.1 Overview
8.2 Global Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
8.3 Infectious Diseases:
8.3.1 Overview
8.3.2 Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 COVID-19
8.3.2.1.1 Overview
8.3.2.1.2 COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Tuberculosis
8.3.2.2.1 Overview
8.3.2.2.2 Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.3 Lyme
8.3.2.3.1 Overview
8.3.2.3.2 Lyme: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.4 Infection Management
8.3.2.4.1 Overview
8.3.2.4.2 Infection Management: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.5 Zika
8.3.2.5.1 Overview
8.3.2.5.2 Zika: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.6 Treponema
8.3.2.6.1 Overview
8.3.2.6.2 Treponema: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.7 TORCH
8.3.2.7.1 Overview
8.3.2.7.2 TORCH: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.8 Measles and Mumps
8.3.2.8.1 Overview
8.3.2.8.2 Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.9 VZV
8.3.2.9.1 Overview
8.3.2.9.2 VZV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.3.2.10 EBV
8.3.2.10.1 Overview
8.3.2.10.2 EBV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.4 Hepatitis+HIV:
8.4.1 Overview
8.4.2 Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.5 Gastrointestinal
8.5.1 Overview
8.5.2 Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.6 Metabolic Disorders
8.6.1 Overview
8.6.2 Metabolics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7 Endocrinology
8.7.1 Overview
8.7.2 Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.3 Hypertension
8.7.3.1 Overview
8.7.3.2 Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.4 Growth
8.7.4.1 Overview
8.7.4.2 Growth: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.5 Diabetes
8.7.5.1 Overview
8.7.5.2 Diabetes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.6 Thyroid
8.7.6.1 Overview
8.7.6.2 Thyroid: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.7.7 Reproductive Endocrinology
8.7.7.1 Overview
8.7.7.2 Reproductive Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9. Immunodiagnostics Market Analysis – End User
9.1 Overview
9.2 Global Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.6 Academic and Research Institutes
9.6.1 Overview
9.6.2 Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
10. Immunodiagnostics Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Immunodiagnostics Market
10.1.1 Overview
10.1.2 North America: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.3.1 North America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.4 North America: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.1.4.1 North America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.4.2 North America: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.5 North America: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.5.1 US: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.3 US: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.5.1.3.1 US: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4 US: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4.1 US: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.4.2 US: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.5 US: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.5.2 Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.3 Canada: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.5.2.3.1 Canada: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4 Canada: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4.1 Canada: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.4.2 Canada: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.5 Canada: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.1.5.3 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.3 Mexico: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.1.5.3.3.1 Mexico: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4 Mexico: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4.1 Mexico: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.4.2 Mexico: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.5 Mexico: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2 Europe: Immunodiagnostics Market
10.2.1 Overview
10.2.2 Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.3.1 Europe: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.4 Europe: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.2.4.1 Europe: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.4.2 Europe: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5 Europe: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.1 UK: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.1 Overview
10.2.5.1.2 UK: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.3 UK: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.1.3.1 UK: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4 UK: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4.1 UK: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.4.2 UK: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.1.5 UK: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.2 Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.1 Overview
10.2.5.2.2 Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.3 Germany: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.2.3.1 Germany: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4 Germany: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4.1 Germany: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.4.2 Germany: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.2.5 Germany: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.3 France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.1 Overview
10.2.5.3.2 France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.3 France: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.3.3.1 France: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4 France: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4.1 France: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.4.2 France: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.3.5 France: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.4 Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.1 Overview
10.2.5.4.2 Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.3 Italy: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.4.3.1 Italy: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4 Italy: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4.1 Italy: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.4.2 Italy: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.4.5 Italy: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.5 Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.1 Overview
10.2.5.5.2 Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.3 Spain: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.5.3.1 Spain: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4 Spain: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4.1 Spain: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.4.2 Spain: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.5.5 Spain: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.2.5.6 Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.1 Overview
10.2.5.6.2 Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.3 Rest of Europe: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.2.5.6.3.1 Rest of Europe: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4 Rest of Europe: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4.1 Rest of Europe: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.4.2 Rest of Europe: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.2.5.6.5 Rest of Europe: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3 Asia Pacific: Immunodiagnostics Market
10.3.1 Overview
10.3.2 Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.3.1 Asia Pacific: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.4 Asia Pacific: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.3.4.1 Asia Pacific: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.4.2 Asia Pacific: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5 Asia Pacific: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.1 China: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.1 Overview
10.3.5.1.2 China: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.3 China: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.1.3.1 China: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4 China: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4.1 China: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.4.2 China: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.1.5 China: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.2 Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.1 Overview
10.3.5.2.2 Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.3 Japan: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.2.3.1 Japan: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4 Japan: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4.1 Japan: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.4.2 Japan: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.2.5 Japan: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.3 India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.1 Overview
10.3.5.3.2 India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.3 India: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.3.3.1 India: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4 India: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4.1 India: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.4.2 India: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.3.5 India: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.4 Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.1 Overview
10.3.5.4.2 Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.3 Australia: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.4.3.1 Australia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4 Australia: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4.1 Australia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.4.2 Australia: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.4.5 Australia: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.5 South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.1 Overview
10.3.5.5.2 South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.3 South Korea: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.5.3.1 South Korea: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4 South Korea: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4.1 South Korea: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.4.2 South Korea: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.5.5 South Korea: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.3.5.6 Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.1 Overview
10.3.5.6.2 Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.3 Rest of Asia Pacific: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.3.5.6.3.1 Rest of Asia Pacific: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4 Rest of Asia Pacific: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4.1 Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.4.2 Rest of Asia Pacific: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.3.5.6.5 Rest of Asia Pacific: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4 Middle East & Africa: Immunodiagnostics Market
10.4.1 Overview
10.4.2 Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.3.1 Middle East & Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.4 Middle East & Africa: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.4.4.1 Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.4.2 Middle East & Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5 Middle East & Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4.5.1 UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.3 UAE: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.5.1.3.1 UAE: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4 UAE: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4.1 UAE: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.4.2 UAE: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.5 UAE: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4.5.2 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.3 Saudi Arabia: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4.1 Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.4.2 Saudi Arabia: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4.5.3 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.3 South Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.5.3.3.1 South Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4 South Africa: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4.1 South Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.4.2 South Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.5 South Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.4.5.4 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.4.5.4.3.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4.1 Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.4.2 Rest of Middle East & Africa: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.5 Rest of Middle East & Africa: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.5 South & Central America: Immunodiagnostics Market
10.5.1 Overview
10.5.2 South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South & Central America: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.5.3.1 South & Central America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.5.4 South & Central America: Immunodiagnostics Market, by Clinical Indication – 2020–2030 (US$ Million)
10.5.4.1 South & Central America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.5.4.2 South & Central America: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.5.5 South & Central America: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.5.5.1 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.1 Overview
10.5.5.1.2 Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.3 Brazil: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.5.5.1.3.1 Brazil: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.4 Brazil: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.4.1 Brazil: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.4.2 Brazil: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.5.5.1.5 Brazil: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.5.5.2 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.1 Overview
10.5.5.2.2 Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.3 Argentina: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.5.5.2.3.1 Argentina: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.4 Argentina: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.4.1 Argentina: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.4.2 Argentina: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.5.5.2.5 Argentina: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
10.5.5.3 Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.1 Overview
10.5.5.3.2 Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.3 Rest of South & Central America: Immunodiagnostics Market, by Product, 2020–2030 (US$ Million)
10.5.5.3.3.1 Rest of South & Central America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.4 Rest of South & Central America: Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.4.1 Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.4.2 Rest of South & Central America: Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
10.5.5.3.5 Rest of South & Central America: Immunodiagnostics Market, by End User, 2020–2030 (US$ Million)
11. Impact Of COVID-19 Pandemic on Immunodiagnostics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12. Global Immunodiagnostics Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Immunodiagnostics Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 DiaSorin SpA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Danaher Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 PerkinElmer Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Svar Life Science AB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Siemens Healthcare GmbH
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Infectious Diseases and Funding
Table 2. North America Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. US Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. US Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 10. US Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 11. US Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 12. US Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 13. US Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 32. UK Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 33. UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 34. UK Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 35. UK Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 36. UK Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 37. UK Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 38. Germany Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 39. Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 40. Germany Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 41. Germany: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 42. Germany Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 43. Germany Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 44. France Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 45. France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 46. France Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 47. France: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 48. France Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 49. France Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 50. Italy Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 51. Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 56. Spain Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 57. Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 62. Rest of Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 63. Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 68. Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 69. Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 74. China Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 75. China Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 76. China Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 77. China Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 78. China Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 79. China Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 80. Japan Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 81. Japan Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 86. India Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 87. India Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 88. India Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 89. India: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 90. India Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 91. India Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 92. Australia Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 93. Australia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 98. South Korea Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 99. South Korea Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 103. South Korea Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 104. Rest of Asia Pacific Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 105. Rest of Asia Pacific Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 110. Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 111. Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 116. UAE Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 117. UAE Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 118. UAE Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 119. UAE Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 120. UAE Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 121. UAE Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 124. Saudi Arabia Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 125. Saudi Arabia: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 126. Saudi Arabia Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 127. Saudi Arabia Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 128. South Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 129. South Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 130. South Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 131. South Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 132. South Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 133. South Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of Middle East & Africa Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of Middle East & Africa Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 140. South & Central America Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 141. South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 146. Brazil Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 147. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 152. Argentina Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 153. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 158. Rest of South & Central America Immunodiagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 159. Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Immunodiagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 164. Recent Inorganic Growth Strategies in the Immunodiagnostics Market
Table 165. Recent Organic Growth Strategies in the Immunodiagnostics Market
Table 166. Glossary of Terms, Immunodiagnostics Market
LIST OF FIGURES
Figure 1. Immunodiagnostics Market Segmentation
Figure 2. Immunodiagnostics Market, by Region
Figure 3. Global Immunodiagnostics Market Overview
Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in Immunodiagnostics Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Immunodiagnostics Market, by Geography (US$ Million)
Figure 7. Global Immunodiagnostics Market – Leading Country Markets (US$ Million)
Figure 8. Global Immunodiagnostics Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Immunodiagnostics Market – Revenue Forecast and Analysis – 2021–2030
Figure 17. Global Immunodiagnostics Market, by Geography – Forecast and Analysis (2020–2028)
Figure 18. Market Positioning of Key Players in Immunodiagnostics Market
Figure 19. Immunodiagnostics Market, by Product, 2022 & 2030 (%)
Figure 20. Enzyme-linked Immunosorbent Assays (ELISA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemiluminescence Immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 22. Vitamin D Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 23. HIV Detection: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 24. HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 25. Other Tests: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 26. Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 27. Others: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 28. Global Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
Figure 29. Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 30. COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 31. Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 32. Lyme: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 33. Infection Management: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 34. Zika: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 35. Treponema: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 36. TORCH: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 37. Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 38. VZV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 39. EBV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 41. Gastrointestinal: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 42. Metabolics: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 43. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 44. Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 45. Growth: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 46. Diabetes: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 47. Thyroid: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 48. Reproductive Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 49. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
Figure 50. Global Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
Figure 51. Hospitals: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 52. Clinics: Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
Figure 53. Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 54. Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 55. Others: Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
Figure 56. North America: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 57. North America Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. North America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 59. US: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)
Figure 60. Canada: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 61. Mexico: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 62. Europe: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 63. Europe Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Europe: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 65. UK: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)
Figure 66. Germany: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 67. France: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 68. Italy: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 69. Spain: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 70. Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 71. Asia Pacific: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 72. Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 73. Asia Pacific: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 74. China: Immunodiagnostics market – Revenue and Forecast to 2030 (US$ Million)
Figure 75. Japan: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 76. India: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 77. Australia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 78. South Korea: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 79. Rest of Asia Pacific: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 80. Middle East & Africa: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 81. Middle East & Africa Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 82. Middle East & Africa: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 83. UAE: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 84. Saudi Arabia: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 85. South Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 86. Rest of Middle East & Africa: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 87. South & Central America: Immunodiagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 88. South & Central America Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 89. South & Central America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
Figure 90. Brazil: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 91. Argentina: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 92. Rest of South & Central America: Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 93. Impact of COVID-19 Pandemic on North American Countries Markets
Figure 94. Impact of COVID-19 Pandemic on European Countries Markets
Figure 95. Impact of COVID-19 Pandemic on Asia Pacific Countries Markets
Figure 96. Impact of COVID-19 Pandemic on South & Central American Countries Markets
Figure 97. Impact of COVID-19 Pandemic on Middle East & African Countries Markets
Figure 98. Growth Strategies in the Immunodiagnostics Market
The List of Companies - Immunodiagnostics Market
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- DiaSorin SpA
- Danaher Corporation
- Thermo Fisher Scientific Inc
- PerkinElmer Inc
- Shenzhen Mindray Bio-Medical Electronics Co Ltd
- bioMerieux SA
- Svar Life Science AB
- Siemens Healthineers AG.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For